We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRCL
1276
DELISTED
Stericycle Inc
SRCL
$79K ﹤0.01%
1,250
-3,100
-71% -$183K
AMD icon
1277
Advanced Micro Devices
AMD
$741B
$78K ﹤0.01%
1,733
+125
+8% +$4.6K
WDFC icon
1278
WD-40
WDFC
$3.08B
$78K ﹤0.01%
404
+110
+37% +$20.7K
ATRI
1279
DELISTED
Atrion Corp
ATRI
$78K ﹤0.01%
105
GBT
1280
DELISTED
Global Blood Therapeutics, Inc.
GBT
$78K ﹤0.01%
989
+16
+2% +$948
AIMT
1281
DELISTED
Aimmune Therapeutics
AIMT
$78K ﹤0.01%
2,337
IPGP icon
1282
IPG Photonics
IPGP
$3.57B
$77K ﹤0.01%
534
+165
+45% +$23K
RSPH icon
1283
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$774M
$77K ﹤0.01%
3,500
TU icon
1284
Telus
TU
$16.7B
$77K ﹤0.01%
4,000
WPM icon
1285
Wheaton Precious Metals
WPM
$49.8B
$77K ﹤0.01%
2,620
+107
+4% +$2.92K
BEAT
1286
DELISTED
BioTelemetry, Inc.
BEAT
$77K ﹤0.01%
1,684
+100
+6% +$4.33K
AMLP icon
1287
Alerian MLP ETF
AMLP
$12.9B
$76K ﹤0.01%
1,808
+600
+50% +$25.2K
MSM icon
1288
MSC Industrial Direct
MSM
$6.97B
$76K ﹤0.01%
976
CSOD
1289
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$76K ﹤0.01%
1,308
+925
+242% +$53.5K
CWST icon
1290
Casella Waste Systems
CWST
$5.79B
$75K ﹤0.01%
1,640
-4,570
-74% -$202K
MER.PRK
1291
Bank of America Income Capital Obligation Notes due December 15 2066
MER.PRK
$1.06B
$75K ﹤0.01%
2,800
TRU icon
1292
TransUnion
TRU
$16.2B
$75K ﹤0.01%
883
+133
+18% +$11.1K
WIFI
1293
DELISTED
Boingo Wireless, Inc.
WIFI
$75K ﹤0.01%
6,880
+325
+5% +$3.53K
COLL icon
1294
Collegium Pharmaceutical
COLL
$1.16B
$74K ﹤0.01%
3,598
LMAT icon
1295
LeMaitre Vascular
LMAT
$2.34B
$74K ﹤0.01%
2,070
+590
+40% +$20.4K
MUFG icon
1296
Mitsubishi UFJ Financial
MUFG
$253B
$74K ﹤0.01%
13,757
+1,365
+11% +$7.2K
VSH icon
1297
Vishay Intertechnology
VSH
$5.02B
$74K ﹤0.01%
3,500
LFC
1298
DELISTED
China Life Insurance Company Ltd.
LFC
$74K ﹤0.01%
5,417
PC
1299
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
$74K ﹤0.01%
7,862
-23
-0.3% -$216
FSV icon
1300
FirstService
FSV
$6.58B
$73K ﹤0.01%
790
+230
+41% +$21.7K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.